2010 versus the 2000 consensus criteria in patients with normalised insulin‐like growth factor 1 after transsphenoidal surgery has high predictive values for long‐term recurrence‐free survival in acromegaly - Shen - 2021

Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future in: Endocrine-Related Cancer Volume 23 Issue 12 (2016)

pasireotide

Acromegaly - ScienceDirect

Diagnosis and Treatment of Acromegaly: An Update - Mayo Clinic Proceedings

Elevated insulin‐like growth factor‐1 in patients without clinical evidence of acromegaly - Careless - 2023 - Clinical Endocrinology - Wiley Online Library

(PDF) How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review

Long-term outcomes of transsphenoidal surgery for management of growth hormone–secreting adenomas: single-center results in: Journal of Neurosurgery Volume 133 Issue 5 (2019) Journals

Frontiers Development and Interpretation of Multiple Machine Learning Models for Predicting Postoperative Delayed Remission of Acromegaly Patients During Long-Term Follow-Up

Acromegaly: pathogenesis, diagnosis, and management - ScienceDirect